Simultaneous measurement of cyclosporin A and tacrolimus from dried blood spots by ultra high performance liquid chromatography tandem mass spectrometry

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 883-884, Issue , 2012, Pages 102-107

  Hinchliffe, Edward ^a   Adaway, Joanne E ^a   Keevil, Brian G ^a  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Cyclosporin A; Dried blood spots; Liquid chromatography tandem mass spectrometry; Tacrolimus; Therapeutic drug monitoring

Indexed keywords

CYCLOSPORIN A; DRIED BLOOD SPOTS; LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY; TACROLIMUS; THERAPEUTIC DRUG MONITORING;

BLOOD; CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOSPITALS; LIQUIDS; MASS SPECTROMETRY; PATIENT MONITORING; SOLVENT EXTRACTION;

BLOOD VESSELS;

ASCOMYCIN; CYCLOSPORIN A; METHANOL; TACROLIMUS;

ARTICLE; BLOOD SAMPLING; CAPILLARY BLOOD; DRIED BLOOD SPOT TESTING; DRUG ISOLATION; ELUTION; FILTER; GRAFT RECIPIENT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; ROOM TEMPERATURE; SOLVENT EXTRACTION; TANDEM MASS SPECTROMETRY;

BLOOD SPECIMEN COLLECTION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOSPORINE; DRUG MONITORING; DRUG STABILITY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIMIT OF DETECTION; LINEAR MODELS; REPRODUCIBILITY OF RESULTS; TACROLIMUS; TANDEM MASS SPECTROMETRY;

EID: 84856436233     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2011.05.016     Document Type: Article

References (14)

1. Hallworth M, Watson I. Therapeutic Drug Monitoring and Laboratory Medicine. ACB Venture Publications, ISBN 978-0-902429-42-0.
2. Staatz C.E., Tett S.E. Clin. Pharmacokinet. 2004, 43:623.
3. Oellerich M., Armstrong V.W., Kahan B., Shaw L., Holt D.W., Yatscoff R., et al. Ther. Drug Monit. 1995, 17:642.
4. Yonan N., Martyszczuk R., Machaal A., Baynes A., Keevil B.G. Clin. Transpl. 2006, 20:221.
5. Leichtle A.B., Ceglarek U., Witzigmann H., Gabel G., Thiery J., Fiedler G.M. J. Transplant. 2010, (Article ID 201918).
6. Edelbroek P.M., van der Heijden J., Stolk L.M.L. Ther. Drug Monit. 2009, 31:327.
7. Wilheim A.J., den Burger J.C.G., Vos R.M., Chahbouni A., Sinjewel A. J. Chromatogr. B 2009, 877:1595.
8. Hoogstanders K., van der Heijden J., Christiaans M., Edelbroek P., van Hooff J.P., Stolk L.M.L. J. Pharm. Biomed. Anal. 2007, 44:658.
9. Keevil B.G., McCann S.J., Cooper D.P., Morris M.R. Ann. Clin. Biochem. 2002, 39:487.
10. Keevil B.G., Tierney D.P., Cooper D.P., Morris M.R., Machaal A., Yonan N. Ther. Drug Monit. 2002, 24:757.
11. Food and Drug Administration Department of Health and Human Services, Guidance for Industry: Bioanalytical Method Validation 2001, http://www.fda.gov/cder/Guidance/4252fnl.pdf.
12. Merton G., Jones K., Lee M., Johnston A., Holt D. Ther. Drug Monit. 2000, 22:594.
13. Keevil B.G., Fildes J., Baynes A., Yonan N. Ann. Clin. Biochem. 2009, 46:144.
14. Webb N.J.A., Roberts D., Preziosi R., Keevil B.G. Pediatr. Transplant. 2005, 9:729.